Cystic fibrosis drug set for rejection

A €220,000 `wonder drug' to treat cystic fibrosis is set to be rejected for use in the Irish health service.

Susan Mitchell

Deputy Editor and Health Editor @susmitchellsbp
20th January, 2013

A €220,000 "wonder drug" to treat cystic fibrosis (CF) is set to be rejected for use in the Irish health service after the manufacturer was told there were serious obstacles to the Irish taxpayer covering the cost.

Kalydeco, which is manufactured by Vertex Pharmaceuticals, is the first and only drug that treats the underlying cause of CF rather than the symptoms of the condition.

It is too early to say whether Kalydeco will be a...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The year in review

Legacy Richie Oakley 1 year ago

Newsround: What Thursday’s papers say

Legacy Leanna Byrne 5 years ago

More cycle routes, expansion of Luas to Bray and new bus network proposed

Legacy Digital Desk 5 years ago